Assenagon Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-57,128
| Closed | -$30.6K | – | 1348 |
|
|
2024
Q4 | $30.6K | Sell |
57,128
-387,057
| -87% | -$207K | ﹤0.01% | 1280 |
|
|
2024
Q3 | $782K | Buy |
444,185
+183,396
| +70% | +$323K | ﹤0.01% | 1150 |
|
|
2024
Q2 | $305K | Sell |
260,789
-10,368
| -4% | -$12.1K | ﹤0.01% | 1284 |
|
|
2024
Q1 | $2.45M | Hold |
271,157
| – | – | 0.01% | 794 |
|
|
2023
Q4 | $2.95M | Sell |
271,157
-240,036
| -47% | -$2.61M | 0.01% | 761 |
|
|
2023
Q3 | $4.12M | Sell |
511,193
-171,298
| -25% | -$1.38M | 0.01% | 600 |
|
|
2023
Q2 | $7.41M | Hold |
682,491
| – | – | 0.03% | 393 |
|
|
2023
Q1 | $4.71M | Buy |
682,491
+232,543
| +52% | +$1.6M | 0.02% | 574 |
|
|
2022
Q4 | $1.79M | Sell |
449,948
-77,977
| -15% | -$310K | 0.01% | 817 |
|
|
2022
Q3 | $3.51M | Buy |
527,925
+420,802
| +393% | +$2.8M | 0.01% | 541 |
|
|
2022
Q2 | $518K | Buy |
+107,123
| New | +$518K | ﹤0.01% | 1174 |
|
|
2022
Q1 | – | Sell |
-84,402
| Closed | -$1M | – | 1534 |
|
|
2021
Q4 | $1M | Sell |
84,402
-7,699
| -8% | -$91.5K | ﹤0.01% | 991 |
|
|
2021
Q3 | $1.05M | Hold |
92,101
| – | – | ﹤0.01% | 855 |
|
|
2021
Q2 | $1.65M | Hold |
92,101
| – | – | 0.01% | 717 |
|
|
2021
Q1 | $1.43M | Hold |
92,101
| – | – | 0.01% | 773 |
|
|
2020
Q4 | $1.12M | Hold |
92,101
| – | – | ﹤0.01% | 669 |
|
|
2020
Q3 | $1.18M | Buy |
+92,101
| New | +$1.18M | 0.01% | 712 |
|